IBIDS syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:453
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

IBIDS syndrome, also known as Tay syndrome or trichothiodystrophy with ichthyosis, is a rare autosomal recessive disorder belonging to the trichothiodystrophy (TTD) spectrum. The acronym IBIDS stands for Ichthyosis, Brittle hair, Impaired intelligence, Decreased fertility, and Short stature, which represent the cardinal features of the condition. It is caused by mutations in genes involved in nucleotide excision repair and transcription, most commonly the ERCC2 (XPD) gene, and less frequently ERCC3 (XPB) or GTF2H5 (TTDA). These genes encode components of the TFIIH transcription/repair complex, and their dysfunction leads to defective DNA repair and transcriptional abnormalities. The condition affects multiple body systems. The hair is characteristically brittle, sparse, and sulfur-deficient, showing a distinctive 'tiger tail' pattern under polarized light microscopy due to alternating light and dark bands. The skin manifests congenital ichthyosis (fish-scale-like dry skin), and patients may also have nail dystrophy. Neurological involvement includes intellectual disability of variable severity, and affected individuals typically exhibit short stature and decreased fertility. Unlike the related PIBIDS variant, classic IBIDS syndrome does not include photosensitivity, though some overlap exists within the TTD spectrum. There is currently no cure for IBIDS syndrome. Management is supportive and multidisciplinary, focusing on symptomatic treatment of ichthyosis with emollients and keratolytic agents, developmental support and special education for intellectual disability, and monitoring of growth. Genetic counseling is recommended for affected families. Prognosis varies depending on the severity of neurological and systemic involvement, and some patients may have a reduced lifespan due to recurrent infections or other complications.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for IBIDS syndrome.

View clinical trials →

No actively recruiting trials found for IBIDS syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the IBIDS syndrome community →

Specialists

1 foundView all specialists →
CM
Clifton Fuller, MD
Houston, Texas
Specialist

Rare Disease Specialist

PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to IBIDS syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open IBIDS syndromeForum →

No community posts yet. Be the first to share your experience with IBIDS syndrome.

Start the conversation →

Latest news about IBIDS syndrome

Disease timeline:

New trial: Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adapti

Phase PHASE2 trial recruiting. Pravastatin (drug)

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about IBIDS syndrome

What is IBIDS syndrome?

IBIDS syndrome, also known as Tay syndrome or trichothiodystrophy with ichthyosis, is a rare autosomal recessive disorder belonging to the trichothiodystrophy (TTD) spectrum. The acronym IBIDS stands for Ichthyosis, Brittle hair, Impaired intelligence, Decreased fertility, and Short stature, which represent the cardinal features of the condition. It is caused by mutations in genes involved in nucleotide excision repair and transcription, most commonly the ERCC2 (XPD) gene, and less frequently ERCC3 (XPB) or GTF2H5 (TTDA). These genes encode components of the TFIIH transcription/repair complex,

How is IBIDS syndrome inherited?

IBIDS syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does IBIDS syndrome typically begin?

Typical onset of IBIDS syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat IBIDS syndrome?

1 specialists and care centers treating IBIDS syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.